𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A controlled clinical trial comparing the safety and immunogenicity of a new adjuvanted hepatitis B vaccine with a standard hepatitis B vaccine

✍ Scribed by Juan Dupont; Javier Altclas; Alejandro Lepetic; Mónica Lombardo; Vicente Vázquez; Claudia Salgueira; Mauricio Seigelchifer; Nathaly Arndtz; Ernesto Antunez; Kenneth von Eschen; Zbigniew Janowicz


Book ID
116959141
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
272 KB
Volume
24
Category
Article
ISSN
0264-410X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Safety and immunogenicity of a recombina
✍ E. Dandolos; A. Roumeliotou-Karayannis; S. C. Richardson; Prof. G. Papaevangelou 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

A hepatitis B vaccine produced in yeast by recombinant DNA technology was evaluated using 5-micrograms and 10-micrograms doses in a randomized trial lasting 7 months in 110 male armed forces recruits aged 17-19 years. Results were compared to those of an identical trial of a plasma-derived vaccine.